Relevant evidence is summarized in Table SII (preclinical studies) (13,69,151,152,181-190) and Table SIII (clinical studies) (73,175,179,180,182,191-199)
In June 2023, Pfizer's official website announced that the company would continue to invest resources in the Danuglipron project for subsequent clinical trial research, including the ongoing Phase 2b study
How to use How to use Take an appropriate amount of the product and spread it evenly
Most patients were managed on-site with poison center follow-up and not referred into a healthcare facility, likely due to the large number of double doses that remained within a therapeutic dosing range (Table 3)
Isnt the statement .with no malice aforethought akin to saying I dont wish to be rude, but. Why make a point of such a statement when the irony is that the whole study is designed to cut down on perceived (and not scientifically backed up) excess treatment which served to harm patients and did not, by any stretch of the imagination prevent illness
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, et al